AFANIX 40 MG
Afatinib is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose
LENVAXEN 4 MG
DESCRIPTION Lenvaxen Lenvatinib 4 mg & 10 mg COMPOSITION LENVAXEN 4 capsules: Each capsule contains Lenvatinib Mesylate INN equivalent to
OLANIB 150 MG
DESCRIPTION Olanib (Olaparib) Olanib is used for the returning treatment of some types of ovarian cancer in patients who have